# HAEMONETICS CORP (HAE) MD&A by fiscal year

Verbatim Item 7 Management's Discussion and Analysis sections from HAEMONETICS CORP's 10-K filings, one page per fiscal year. Extracted from SEC filings with the same bounded parser for every year. Filer text, not grepcent analysis or investment advice.

- [FY 2026 MD&A](/company/HAE/mda/fy2026/): filed 2026-05-20; accession 0000313143-26-000050 (https://www.sec.gov/Archives/edgar/data/313143/000031314326000050/hae-20260328.htm); latest 10-K
- [FY 2025 MD&A](/company/HAE/mda/fy2025/): filed 2025-05-21; accession 0000313143-25-000025 (https://www.sec.gov/Archives/edgar/data/313143/000031314325000025/hae-20250329.htm)
- [FY 2024 MD&A](/company/HAE/mda/fy2024/): filed 2024-05-20; accession 0000313143-24-000020 (https://www.sec.gov/Archives/edgar/data/313143/000031314324000020/hae-20240330.htm)
- [FY 2023 MD&A](/company/HAE/mda/fy2023/): filed 2023-05-22; accession 0000313143-23-000014 (https://www.sec.gov/Archives/edgar/data/313143/000031314323000014/hae-20230401.htm)
- [FY 2022 MD&A](/company/HAE/mda/fy2022/): filed 2022-05-25; accession 0000313143-22-000024 (https://www.sec.gov/Archives/edgar/data/313143/000031314322000024/hae-20220402.htm)

Back to /company/HAE/